A U.S. federal appeals court said Sanofi SA and partner Regeneron Pharmaceuticals Inc. can keep selling their cholesterol drug while they challenge a patent-infringement ruling by a lower court that threatened to halt sales.
from WSJ.com: US Business http://ift.tt/2k58wfi
via IFTTT
No comments:
Post a Comment